SINOPHARM (01099.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec29

Zhou Zhenyu Approved to Serve as Director and General Manager of Sinopharm Group Finance Co.

09:51

Sinopharm Group reaches a strategic cooperation with Tasly Pharmaceutical Group.

08:50

Sinopharm Holdings Actively Prepares Stock for Implementation of New National Medical Insurance Drug Catalog

08:43

Dec27

Sinopharm Group will participate in the 92nd National Drug Fair

15:11

A subsidiary of Sinopharm Group has its application for a generic Crisaborole ointment accepted

01:00

Dec26

Sinopharm's Subsidiary Listed as a Distributor for Non-Immunization Program Vaccines in Hubei Province

00:00

Schedules & Filings

Schedules

Filings

Oct21

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 158.99 B, Net Income 2.021 B, EPS 3.6093

Aug24

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 158.03 B, Net Income 2.19 B, EPS 0.6995

Aug22

Earning Release(CST)

FY2025 Semi-Annual Earning Release

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change